Pharmacodynamics and therapeutic applications of iboga and ibogaine
in psychotherapy and for controlling narcotic dependence.
On the basis of word of mouth, the ibogaine
scene has quadrupled in the last 5 years," says Ken Alper, a psychiatrist at the New York University School of Medicine in New York City.
In the past, Ibogaine
treatment has only been available privately at pounds 500 a time.
But at least four people with heart and liver problems have died after taking Ibogaine
Surprisingly, few analogues of ibogaine
have been synthesized and evaluated.
27, 2015 /PRNewswire/ -- Rythmia Life Advancement Center (RLAC) today announced the launch of its new addiction rehabilitation facility in Costa Rica which will utilize the Iboga plant and Ibogaine
as part of their treatment plan.
Major LSD Psilocybe mushrooms Mescaline cacti Salvia divinorum DMT (ayaltuasca, yopo, etc.
John's Hypericum Leaves and Phloroglucinol derivatives (hyperforin, adhyperforin), anthraquinone wort perforatum flowering tops derivatives (hypericin, pseudohypericin) Kudzu Pueraria lobata Flowers and Isoflavons roots derivatives (daidzin, daidzein) Danshen Salvia Roots Diterpene compounds miltiorrhiza (tanshinones, miltirone) Tabernanthe Tabernanthe Roots Ibogaine
iboga Ginseng Panax ginseng Roots Ginsenosides Evening Oenothera Oil GLA (an omega 6 primrose biennis fatty acid) Milk Thistle Silybum marianum Fruits Silymarin, a complex of 5 flavanolignans Scullcap Scutellaria Aerial parts Flavonoids laterifolia (scutellarin, scutellarein), iridoids (catalpol) SKV (a) Agaricus (b) (a) An ayurvedic formula of 12 herbal ingredients.
, psilocybin mushrooms and peyote) have a long history of use within a medical or religious context (e.
Lex Kogan, Ibogaine
developer, has spoken out in support of a recent CDC question-and-answer session.
has resurfaced as a non-FDA approved, experimental detoxification treatment for heroin and other addictions, but it wasn't until I read Marlene's book that I understood iboga's cultural origins.
18-MC was the result of rational drug design program aimed at generating a molecule with anti-addictive properties that lacked the toxicities seen with ibogaine